As part of the country's health reform efforts, the Chinese government has issued a list of more than 300 commonly used medicines that will be sold at controlled prices beginning in September. Public hospitals and doctors often rely on profits from the sale of drugs and expensive treatments and tests to cover their operating expenses. The facilities have been accused of aggressively prescribing expensive and sometimes unnecessary drugs and treatment, according to the Associated Press.